Observations on the treatment of leprosy with Lederkyn, DDS and new tuberculostatic substances.
D002986:Clinical Trials as Topic; D003168:Complement Fixation Tests; D003622:Dapsone / Q000627:therapeutic use*; D004338:Drug Combinations; D004977:Ethambutol / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007918:Leprosy / Q000188:drug therapy*; D012293:Rifampin / Q000009:adverse effects / Q000627:therapeutic use; D013421:Sulfamethoxypyridazine / Q000627:therapeutic use*; D013450:Sulfones / Q000009:adverse effects
D004338:Drug Combinations; D013450:Sulfones; D004977:Ethambutol; D003622:Dapsone; D013421:Sulfamethoxypyridazine; D012293:Rifampin